Strong sales of Xience stents overseas and diagnostics tools back home contribute to Abbott's $7.7 billion in first-quarter revenues; net profit tops $1 billion, down 30 percent from 2009 levels.
Paced by strong international growth, coronary stent sales for Abbott (NYSE:ABT) rose 13 percent during the first three months of 2010, to $455 million.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...